97 related articles for article (PubMed ID: 21742397)
1. Successful treatment with continuous subcutaneous insulin infusion for allergy to human insulin and its analogs.
Zhang L; Zhang M; Liu YY; Hu M; Zhou X; Luo Y
Diabetes Res Clin Pract; 2011 Oct; 94(1):e1-2. PubMed ID: 21742397
[TBL] [Abstract][Full Text] [Related]
2. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
[TBL] [Abstract][Full Text] [Related]
3. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.
Radermecker RP; Scheen AJ
Diabetes Metab Res Rev; 2007 Jul; 23(5):348-55. PubMed ID: 17216593
[TBL] [Abstract][Full Text] [Related]
4. [Consensus document on continuous subcutaneous insulin infusion (CSII) treatment in paediatrics with type I diabetes].
Barrio Castellanos R; García Cuartero B; Gómez Gila A; González Casado I; Hermoso López F; Luzuriaga Tomás C; Oyarzabal Irigoyen M; Rica Etxebarria I; Rodríguez Rigual M; Torres Lacruz M;
An Pediatr (Barc); 2010 May; 72(5):352.e1-4. PubMed ID: 20409767
[TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous insulin infusion--an historical perspective.
Skyler JS
Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S5-9. PubMed ID: 20515307
[No Abstract] [Full Text] [Related]
6. Systemic allergy to human insulin and its rapid and long acting analogs: successful treatment by continuous subcutaneous insulin lispro infusion.
Castéra V; Dutour-Meyer A; Koeppel M; Petitjean C; Darmon P
Diabetes Metab; 2005 Sep; 31(4 Pt 1):391-400. PubMed ID: 16369203
[TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous insulin infusion providing better glycemic control and quality of life in Type 2 diabetic subjects hospitalized for marked hyperglycemia.
Lee IT; Liau YJ; Lee WJ; Huang CN; Sheu WH
J Eval Clin Pract; 2010 Feb; 16(1):202-5. PubMed ID: 20367835
[No Abstract] [Full Text] [Related]
8. Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin.
Sola-Gazagnes A; Pecquet C; Radermecker R; Piétri L; Elgrably F; Slama G; Sélam JL
Diabetes Care; 2003 Oct; 26(10):2961-2. PubMed ID: 14514615
[No Abstract] [Full Text] [Related]
9. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
Mollar-Puchades MA; Villanueva IL
Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
[TBL] [Abstract][Full Text] [Related]
10. Insulin therapy in children and adolescents with diabetes.
Galli-Tsinopoulou A
Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S114-7. PubMed ID: 21864742
[TBL] [Abstract][Full Text] [Related]
11. Continuous insulin infusion systems in type 2 diabetes.
Kesavadev J
J Assoc Physicians India; 2011 Apr; 59 Suppl():41-3. PubMed ID: 21818997
[TBL] [Abstract][Full Text] [Related]
12. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
Shashaj B; Busetto E; Sulli N
Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
[TBL] [Abstract][Full Text] [Related]
13. Continuous subcutaneous insulin usage in a patient with no gut.
Annamalai AK; Mankia S; Kandasamy N; Donald S; Adler AI
Diabet Med; 2010 Mar; 27(3):364-6. PubMed ID: 20536503
[No Abstract] [Full Text] [Related]
14. Patient management of long-term continuous subcutaneous insulin infusion.
Johansson UB; Adamson U; Lins PE; Wredling R
J Adv Nurs; 2005 Jul; 51(2):112-8. PubMed ID: 15963182
[TBL] [Abstract][Full Text] [Related]
15. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C
Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
[TBL] [Abstract][Full Text] [Related]
16. A practical, clinical approach to the assessment and management of suspected insulin allergy.
Jacquier J; Chik CL; Senior PA
Diabet Med; 2013 Aug; 30(8):977-85. PubMed ID: 23601039
[TBL] [Abstract][Full Text] [Related]
17. Allergic reactions to human insulin: a review of current knowledge and treatment options.
Akinci B; Yener S; Bayraktar F; Yesil S
Endocrine; 2010 Feb; 37(1):33-9. PubMed ID: 19876775
[TBL] [Abstract][Full Text] [Related]
18. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
19. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
Bruttomesso D; Costa S; Baritussio A
Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
[TBL] [Abstract][Full Text] [Related]
20. Resource utilization with insulin pump therapy for type 2 diabetes mellitus.
Lynch PM; Riedel AA; Samant N; Fan Y; Peoples T; Levinson J; Lee SW
Am J Manag Care; 2010; 16(12):892-6. PubMed ID: 21348559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
